Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from PMLIVE

14:58 EDT 17th July 2018 | BioPortfolio

Here are the most relevant search results for "PMLIVE" found in our extensive news archives from over 250 global news sources.

More Information about PMLIVE on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PMLIVE for you to read. Along with our medical data and news we also list PMLIVE Clinical Trials, which are updated daily. BioPortfolio also has a large database of PMLIVE Companies for you to search.

Showing News Articles 1–25 of 962 from PMLIVE

Tuesday 17th July 2018

Pfizer enters late-stage haemophilia B gene therapy trial

Race is on to free patients of regular injections

Roche’s Tamiflu successor hits the mark in complicated flu

Baloxavir marboxil met its primary objective and cut flu-related complications

Novartis launch NET cancer community app

Galaxies of Hope aims to provide support to cancer patients

J&J’s Invokana aces diabetic kidney disease trial, setting up filings

It could be the first new drug in 15 years to slow kidney damage development

Monday 16th July 2018

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

News from pharma, biotech and healthcare

‘Common Rulebook’ Brexit plans include medicines – but face backlash

Government compromises could be opposed from both sides

MaxCyte gets green light for solid tumour cell therapy

Its first CAR therapy will be tested in patients with ovarian cancer

Novartis rejects claims it misled Senate over Cohen links

Report says Novartis discussed drug-pricing with the President’s former ‘fixer’

Friday 13th July 2018

May’s Brexit plan cautiously welcomed by biopharma sector

The white paper says the UK should adhere to EMA regulations post-Brexit

Daily Brief: Novartis exits anti-infectives drive, Hancock takes over from Hunt and Trump attacks 'soft Brexit' plan

The latest from pharma, biotech and healthcare

GSK sells eczema and psoriasis drug to Dermavant for £250m

The British group is selling off assets outside core therapy areas to boost R&D

Thursday 12th July 2018

Fishawack acquires brand communications agency Healthcircle

The agency will work alongside Fishawack’s medical communication businesses

Roche keeps Venclexta train rolling with new leukaemia filing

The drug could treat AML patients who are ineligible for chemotherapy

Daily Brief: Trump arrives in London, NICE says no to Darzalex, Pfizer backs down on prices

The latest from pharma, biotech and healthcare

Pfizer builds gap between pharma and consumer health units

Its consumer health division will become a standalone unit after lack of buyer interest

Wednesday 11th July 2018

Some pharma companies not prepared for Brexit, warns EMA

Regulator concerned about medicines shortages after March 2019

VC raises new €270m fund for European biotechs

The money will mostly go to companies working on novel therapies

Christina Coughlin to leave Immunocore for Tmunity

UPenn pioneers building their own biotech company

AZ makes gene therapy move with 4DMT alliance

The new partnership will focus on creating an AAV for lung disease

The rise of vertical integration in the US payer landscape

Is it a solution to addressing the challenges of the value-based marketplace?

Tuesday 10th July 2018

Rebecca Grant to lead newly-formed Burson Cohn & Wolfe UK

Experienced leader takes on merged comms group

Daily Brief: Brexit reshuffle brings new health minister, Celgene thalassemia success, Wellcome ready to leap into future

A round-up from pharma, biotech and healthcare

Monday 9th July 2018

Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’

CEO writes open letter to prime minister

CTI slumps as Servier-partnered lymphoma drug fails

NHS England says yes to Roche's Hemlibra

But stalls on funding for Actelion's Uptravi


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks